Chohee Yun

Chohee Yun, MD, serves as the Senior Vice President of Clinical Development at Mirador Therapeutics since June 2025. Prior to this, Chohee Yun held the position of Senior Vice President of Clinical Development at Pliant Therapeutics from June 2024 to May 2025 and served as Vice President of Clinical Development at Ventyx Biosciences from June 2022 to January 2024. At Ventyx Biosciences, Chohee Yun led a S1P receptor modulator program and a TYK2 inhibitor program, overseeing the strategic and executional aspects of clinical trials. Previously, during a tenure at Gilead Sciences from August 2015 to June 2022, Chohee Yun was the Executive Director of Clinical Research in the Inflammation Therapeutic Area, contributing to multiple development programs in inflammatory bowel disease. Chohee Yun also completed a fellowship in Gastroenterology and Hepatology at Stanford Hospital & Clinics from July 2012 to June 2015. Education was completed at Seoul National University with a Doctor of Medicine (M.D.) degree.